| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/09/2007 | CN1957955A Soft capsule of Chinese traditional medicine, preparation method, and quality control method |
| 05/09/2007 | CN1957908A Method for preparing gel of zinc calcium gluconate |
| 05/09/2007 | CN1957754A Health care powder of bitter buckwheat for three degressions, and preparation method |
| 05/09/2007 | CN1314696C 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 05/09/2007 | CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314445C Pulmonary administration of chemically modified insulin |
| 05/09/2007 | CN1314444C Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method |
| 05/09/2007 | CN1314430C Chinese traditional medicine for treating diabetes |
| 05/09/2007 | CN1314423C Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases |
| 05/09/2007 | CN1314411C Medicinal composition, and its preparing method and use |
| 05/09/2007 | CN1314405C Method for applying complete puncturevine herb in preparing medicine for treating insulin resisting hyperglycemia and hypertension |
| 05/09/2007 | CN1314397C Effective site extract of lotus plumule and its usage |
| 05/08/2007 | US7214778 Solvent extraction from plant |
| 05/08/2007 | US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214691 For therapy of metabolic and eating disorders |
| 05/08/2007 | US7214689 Isoquinoline compounds |
| 05/08/2007 | US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/08/2007 | US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | US7214394 Isolating policosanols from a seed or grain processing stream or a vegetable oil processing stream |
| 05/08/2007 | US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 05/08/2007 | US7214387 Antidiabetic agents |
| 05/08/2007 | CA2545658A1 Compositions and methods for weight-loss and weight-loss maintenance in daytime and nighttime formulation |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2328314C Long chain alcohols admixed in sterol compounds |
| 05/08/2007 | CA2215605C Osmotically controlled fermentation process for the preparation of acarbose |
| 05/03/2007 | WO2007051134A2 Compositions and methods for increasing lean muscle mass and/or reducing fat gain |
| 05/03/2007 | WO2007051095A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 05/03/2007 | WO2007050124A1 Fused piperidine derivatives and their uses as therapeutic agents |
| 05/03/2007 | WO2007049941A1 Bioactive substance carrier for in vivo stable delivery tehreof, conjugate containing the same, and method of in vivo stable delivery of the bioactive substance |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049818A1 Anti-fatty liver, anti-obesity or hypolipidemic composition |
| 05/03/2007 | WO2007049798A1 Novel benzoxathiin derivative |
| 05/03/2007 | WO2007049796A2 Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| 05/03/2007 | WO2007049695A1 Agglutinable glp-1 analogue and sustained-release pharmaceutical composition |
| 05/03/2007 | WO2007049359A1 Method of controlling glucose metabolism |
| 05/03/2007 | WO2007049121A1 Crystal form of sodium; (3r,5r)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxy-heptanoate |
| 05/03/2007 | WO2007049119A1 A novel compound, useful for pancreatic lipase inhibition and the process for isolation thereof |
| 05/03/2007 | WO2007048843A2 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | WO2007048842A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 05/03/2007 | WO2007048840A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 05/03/2007 | WO2007048802A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 05/03/2007 | WO2007048510A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 05/03/2007 | WO2007048333A1 The use of ginkgo biloba extract in preparation of a composition for lowering cholesterol |
| 05/03/2007 | WO2007022488A3 Crystalline rosuvastatin intermediate |
| 05/03/2007 | WO2007010337A8 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 05/03/2007 | WO2007006319A3 Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| 05/03/2007 | WO2006123358A3 Stabilized atorvastatin-containing formulation |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070100561 Crystals of DPP-IV |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099990 N-(3-(p-Isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof; cerebrovascular disorders |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099979 New pyrazole derivatives and diabetic medicine containing them |
| 05/03/2007 | US20070099958 Protease inhibitors |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099853 Agent for improving physiological motor functions |
| 05/03/2007 | US20070099836 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098761 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 05/03/2007 | US20070098734 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma, insulin dependent diabetes, arthritis |
| 05/03/2007 | US20070098680 Agent for treating diabetes mellitus |
| 05/03/2007 | DE102005052127A1 Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New indol-containing beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052103A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052102A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052101A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005012873B4 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2627486A1 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2627477A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 05/03/2007 | CA2627403A1 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2627139A1 Novel benzoxathiin derivative |
| 05/03/2007 | CA2627090A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 05/03/2007 | CA2626747A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 05/03/2007 | CA2625967A1 Compositions and methods for increasing lean muscle mass and/or reducing fat gain |
| 05/03/2007 | CA2624383A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 05/03/2007 | CA2622600A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
| 05/02/2007 | EP1780210A1 Novel cyclic aminobenzoic acid derivative |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780200A1 A crystalline form of fluvastatin sodium and a process for preparing it |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1779862A1 Erythropoietin for stimulating endothelial progenitor cells |
| 05/02/2007 | EP1779861A1 Use of nerve growth factor (NGF) for the preparation of a medicament for the stimulation of weight loss |
| 05/02/2007 | EP1779857A1 Use of selenium compounds, especially selenium yeasts in the treatment of Alzheimer, neurodegenerative diseases and diabetes |
| 05/02/2007 | EP1778693A2 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 05/02/2007 | EP1778690A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 05/02/2007 | EP1778682A1 Heterocyclic compounds useful as dpp- iv inhibitors |
| 05/02/2007 | EP1778657A1 Fluorination process of protected aminothiazole |
| 05/02/2007 | EP1778655A1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |